Drawing for ENUIFY

USPTO serial 88478510

ENUIFY

Reviewed by CopyMark Law Group

Status 605
Filing date
Status date
Registration date
Examiner
FALK, ERIN
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with ENUIFY?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005parenterally-administered pharmaceuticals for treatment of cysteine-deficient newborns and infants; pharmaceuticals for treatment of cysteine-deficient newborns and infants; pharmaceuticals for treatment of cysteine deficienciesABANDONED

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 2, 2020MAB5ABANDONMENT NOTICE E-MAILED - AFTER PUBLICATION
Jul 2, 2020ABN5ABANDONMENT - AFTER PUBLICATION
Jul 1, 2020CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jul 1, 2020TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 1, 2020ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 1, 2020REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 1, 2020COARTEAS CHANGE OF OWNER ADDRESS RECEIVED
Jul 1, 2020EXARTEAS EXPRESS ABANDONMENT RECEIVED
Jun 30, 2020CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jun 30, 2020TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 30, 2020ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 30, 2020REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 30, 2020COARTEAS CHANGE OF OWNER ADDRESS RECEIVED
Apr 29, 2020ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Apr 24, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 22, 2020EX1GSOU EXTENSION 1 GRANTED
Apr 22, 2020EXT1SOU EXTENSION 1 FILED
Apr 22, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 26, 2019NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Oct 1, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 1, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 11, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 23, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Aug 23, 2019DOCKASSIGNED TO EXAMINER
Jun 28, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 21, 2019NWAPNEW APPLICATION ENTERED

Frequently asked questions

Related guidance